Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Anticoagulant cyclic diaza compounds reported by Cor Therapeutics

Dec. 15, 1998

First launch for Novartis anticoagulant takes place in Germany

Dec. 15, 1998

Novel anticoagulant serpin described by U.S. academics

Dec. 14, 1998

Avigen presents results of preclinical testing of hemophilia gene therapy and plans clinical trials

Dec. 10, 1998

The Medicines Company begins phase III testing of Hirulog in heart attack patients

Dec. 10, 1998

Prodrug of platelet gpIIb/IIIa receptor antagonist with excellent intranasal antithrombotic efficacy

Dec. 9, 1998

Australian university scientists design new diflunisal esters with improved characteristics

Dec. 8, 1998

Centocor will market Retavase exclusively in the U.S. starting in January

Dec. 4, 1998

Pharming and Gem to codevelop human lactoferrin (GPX-400) to neutralize heparin

Dec. 4, 1998

rNAPc2 enters phase II trials in U.S. and Europe

Dec. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...